Viewing nowCombinationTelmisartan and Amlodipine Besilate Tablets 80/10 mg
Telmisartan 80mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Jeil Health Science Co., Ltd.

MFDS item code 202500848 · Approved 2025.04.10 · Insurance code 054301400
Treatment of essential hypertension not controlled with monotherapy
Essential hypertension refers to a condition where blood pressure remains consistently high. If blood pressure is not sufficiently controlled with telmisartan or amlodipine monotherapy, this medication helps lower blood pressure effectively and reduce the risk of cardiovascular diseases. Therefore, this medication is used for the treatment of essential hypertension.
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended to take it at the same time each day (e.g., in the morning). Before administering this medicine, it is recommended that the dose be adjusted using the individual components (telmisartan or amlodipine); however, direct conversion to this medicine may be considered if blood pressure is not controlled with the individual components as follows. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. - 80/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or this medicine 40/10 mg. Patients taking telmisartan and amlodipine in combination may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience (limited to this medicine 40/5 mg and 80/10 mg). ○ Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. However, in patients with severe renal impairment, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of telmisartan should not exceed 40 mg. ○ Older adults: In adults aged 75 years and older, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually.
○ Pediatric patients: Administration of this drug is not recommended because its safety and efficacy have not been established in pediatric patients 18 years of age or younger.
This medication can pose serious risks to the fetus and newborn during pregnancy, especially in the second and third trimesters, so it should not be taken by pregnant women or women who may become pregnant. It should not be administered to patients with allergies to the ingredients or similar drugs, or those with specific liver dysfunction, heart valve disease, or severe hypotension. Patients with impaired liver or kidney function, particularly those with severe liver or kidney disorders, require closer monitoring and potential dose adjustments when using this medication. As this medication lowers blood pressure, it can cause hypotension in patients with depletion of fluids or salt, so assessing and monitoring the condition before administration is important. There is a risk of elevated potassium levels in the blood; thus, patients at risk for hyperkalemia should have their potassium levels checked regularly through blood tests. This medication may interact with certain drugs, so if taking other medications, it is important to consult with a doctor or pharmacist, especially when taken with digoxin, lithium, warfarin, or non-steroidal anti-inflammatory drugs. The safety and efficacy of this medication have not been established in children, so it is not recommended for pediatric use. When administered to elderly patients, careful monitoring is required as they may respond more sensitively, and dosage adjustments may be needed. In case of overdose, symptoms such as low blood pressure, dizziness, and changes in heart rate may occur, requiring immediate medical attention and appropriate emergency treatment if necessary. Patients may experience drowsiness or dizziness during treatment, so caution is needed when driving or operating hazardous machinery. Keep out of reach of children, and it is best to take the product out of its packaging just before administration.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light and should be stored in a tightly closed container that protects from light. It is recommended to maintain room temperature between 1 and 30 degrees Celsius to preserve the effectiveness of the medication.
White oval biconvex film-coated tablet
30 tablets (10 tablets/PTPX3), 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan 80mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Jeil Health Science Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
ILDONG Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.